Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

Press releases published on July 15, 2026

Jul. 15, 2026

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

Indeterminate GlobeNewswire

Jul. 15, 2026

Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn

Indeterminate GlobeNewswire

Jul. 15, 2026

Valitor to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Indeterminate GlobeNewswire

Jul. 15, 2026

ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

Indeterminate GlobeNewswire

Jul. 15, 2026

Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform

Indeterminate GlobeNewswire

Jul. 15, 2026

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Indeterminate GlobeNewswire

Jul. 15, 2026

VTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 million

Indeterminate GlobeNewswire

Jul. 15, 2026

Cardiff Oncology Announces $10 Million Registered Direct Offering

Indeterminate GlobeNewswire

Jul. 15, 2026

Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio

Indeterminate GlobeNewswire

Jul. 15, 2026

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Indeterminate GlobeNewswire

Jul. 15, 2026

Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Indeterminate GlobeNewswire

Jul. 15, 2026

InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic Dermatitis

Indeterminate GlobeNewswire

Jul. 15, 2026

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Indeterminate GlobeNewswire

Jul. 15, 2026

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Indeterminate GlobeNewswire

Jul. 15, 2026

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™

Indeterminate GlobeNewswire

Jul. 15, 2026

Repligen to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 15, 2026

Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™…

Indeterminate GlobeNewswire